Digital adherence technology for tuberculosis treatment supervision: A stepped-wedge cluster-randomized trial in Uganda
Open accessThe DOI matches its Crossref record; 20 of the 21 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Adherence to and completion of tuberculosis (TB) treatment remain problematic in many high-burden countries. 99DOTS is a low-cost digital adherence technology that could increase TB treatment completion. METHODS AND FINDINGS: We conducted a pragmatic stepped-wedge cluster-randomized trial including all adults treated for drug-susceptible pulmonary TB at 18 health facilities across Uganda over 8 months (1 December 2018-31 July 2019). Facilities were randomized to switch from routine (control period) to 99DOTS-based (intervention period) TB treatment supervision in consecutive months. Patients were allocated to the control or intervention period based on which facility they attended and their treatment start date. Health facility staff and patients were not blinded to the intervention. The primary outcome was TB treatment completion. Due to the pragmatic nature of the trial, the primary analysis was done according to intention-to-treat (ITT) and per protocol (PP) principles. This trial is registered with the Pan African Clinical Trials Registry (PACTR201808609844917). Of 1,913 eligible patients at the 18 health facilities (1,022 and 891 during the control and intervention periods, respectively), 38.0% were women, mean (SD) age was 39.4 (14.4) years, 46.8% were HIV-infected, and most (91.4%) had newly diagnosed TB. In total, 463 (52.0%) patients were enrolled on 99DOTS during the intervention period. In the ITT analysis, the odds of treatment success were similar in the intervention and control periods (adjusted odds ratio [aOR] 1.04, 95% CI 0.68-1.58, p = 0.87). The odds of treatment success did not increase in the intervention period for either men (aOR 1.24, 95% CI 0.73-2.10) or women (aOR 0.67, 95% CI 0.35-1.29), or for either patients with HIV infection (aOR 1.51, 95% CI 0.81-2.85) or without HIV infection (aOR 0.78, 95% CI 0.46-1.32). In the PP analysis, the 99DOTS-based intervention increased the odds of treatment success (aOR 2.89, 95% CI 1.57-5.33, p = 0.001). The odds of completing the intensive phase of treatment and the odds of not being lost to follow-up were similarly improved in PP but not ITT analyses. Study limitations include the likelihood of selection bias in the PP analysis, inability to verify medication dosing in either arm, and incomplete implementation of some components of the intervention. CONCLUSIONS: 99DOTS-based treatment supervision did not improve treatment outcomes in the overall study population. However, similar treatment outcomes were achieved during the control and intervention periods, and those patients enrolled on 99DOTS achieved high treatment completion. 99DOTS-based treatment supervision could be a viable alternative to directly observed therapy for a substantial proportion of patients with TB. TRIAL REGISTRATION: Pan-African Clinical Trials Registry (PACTR201808609844917).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Health facilities, strategically chosen as clusters in numerous studies, underscore the emphasis on healthcare delivery and interventions within controlled environments.”
From Applications and implementation considerations for stepped-wedge designs in sub-Saharan Africa: a systematic review (2026) · cites this paper as [26]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Administrative units such as districts and wards allowed for evaluating public health interventions across larger populations (26–28, 30, 33, 34, 36, 38, 42, 47, 51, 52, 62, 69, 71–73, 75–79, 84–86, 91, 92, 94–97, 99, 101, 104, 108, 109).”
From Applications and implementation considerations for stepped-wedge designs in sub-Saharan Africa: a systematic review (2026) · cites this paper as [26]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The everyday use of hospitals and clinics as clusters is rooted in their pivotal role in healthcare delivery, enabling the implementation and evaluation of interventions to enhance patient outcomes (26, 27, 30–34, 36–47, 49, 50, 52–71, 73–75, 77–81, 83–89, 91–96, 98–102, 104, 105, 107, 109).”
From Applications and implementation considerations for stepped-wedge designs in sub-Saharan Africa: a systematic review (2026) · cites this paper as [26]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Simple randomization, often using computer-generated sequences, was a standard method employed to determine the order in which clusters received the intervention (26, 30, 32, 35, 38, 47, 58, 65).”
From Applications and implementation considerations for stepped-wedge designs in sub-Saharan Africa: a systematic review (2026) · cites this paper as [26]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Several studies focused on implementing health technologies and digital solutions to improve healthcare delivery and patient outcomes (26, 27, 32, 54, 62, 79, 85, 90, 91, 94, 98, 101, 104, 105).”
From Applications and implementation considerations for stepped-wedge designs in sub-Saharan Africa: a systematic review (2026) · cites this paper as [26]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global tuberculosis report (2014)
Gabbasova, L. A., & Who, E. R. E. (2014) · Cited by 12,702
Directly observed therapy for treating tuberculosis
Karumbi, J., & Garner, P. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003343.pub4 · Cited by 644
Noyes, J., & Popay, J. (2007) · Journal of Advanced Nursing · doi:10.1111/j.1365-2648.2006.04092.x · Cited by 272
Liu, X., Lewis, J. J., Zhang, H., Lu, W., Zhang, S., Zheng, G., Bai, L., Li, J., Li, X., Chen, H., et al. (2015) · PLOS Medicine · doi:10.1371/journal.pmed.1001876 · Cited by 234
Guidelines for treatment of drug-susceptible tuberculosis and patient care-2017 update
Gao, J., Wang, X., Fu, L., & Du, J. (2018) · Chinese Journal of Asthma · doi:10.3760/cma.j.issn.1673-436x.2018.03.001 · Cited by 231
Story, A., Aldridge, R. W., Smith, C. M., Garber, E., Hall, J., Ferenando, G., Possas, L., Hemming, S., Wurie, F., Luchenski, S., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(18)32993-3 · Cited by 213
Browne, S. H., Umlauf, A., Tucker, A. J., Low, J., Moser, K., Gonzalez Garcia, J., Peloquin, C. A., Blaschke, T., Vaida, F., & Benson, C. A. (2019) · PLOS Medicine · doi:10.1371/journal.pmed.1002891 · Cited by 87
Self-citationDigital Health Support in Treatment for Tuberculosis
Yoeli, E., Rathauser, J., Bhanot, S. P., Kimenye, M. K., Mailu, E., Masini, E., Owiti, P., & Rand, D. (2019) · New England Journal of Medicine · doi:10.1056/nejmc1806550 · Cited by 64
McLaren, Z. M., Milliken, A., Meyer, A. J., & Sharp, A. R. (2016) · BMC Infectious Diseases · doi:10.1186/s12879-016-1862-y · Cited by 61
Thekkur, P., Kumar, A. M. V., Chinnakali, P., Selvaraju, S., Bairy, R., Singh, A. R., Nirgude, A. S., Selvaraj, K., Venugopal, V., & Shastri, S. G. (2019) · Global Health Action · doi:10.1080/16549716.2019.1568826 · Cited by 61
Thomas, B. E., Kumar, J. V., Onongaya, C., Bhatt, S. N., Galivanche, A., Periyasamy, M., Chiranjeevi, M., Khandewale, A. S., Ramachandran, G., Shah, D., et al. (2020) · JMIR mHealth and uHealth · doi:10.2196/16634 · Cited by 59
Thomas, B. E., Kumar, J. V., Chiranjeevi, M., Shah, D., Khandewale, A., Thiruvengadam, K., Haberer, J. E., Mayer, K. H., & Subbaraman, R. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa333 · Cited by 55
99DOTS: a low-cost approach to monitoring and improving medication adherence
Cross, A., Gupta, N., Liu, B., Nair, V., Kumar, A., Kuttan, R., Ivatury, P., Chen, A., Lakshman, K., Rodrigues, R., et al. (2019) · Proceedings of the Tenth International Conference on Information and Communication Technologies and Development · doi:10.1145/3287098.3287102 · Cited by 52
Patel, D., Berger, C. A., Kityamuwesi, A., Ggita, J., Kunihira Tinka, L., Turimumahoro, P., Feler, J., Chehab, L., Chen, A. Z., Gupta, N., et al. (2020) · JMIR Formative Research · doi:10.2196/19270 · Cited by 37
Self-citationMoving Beyond Directly Observed Therapy for Tuberculosis
Metcalfe, J. Z., O’Donnell, M. R., & Bangsberg, D. R. (2015) · PLoS Medicine · doi:10.1371/journal.pmed.1001877 · Cited by 24
Crowder, R., Kityamuwesi, A., Kiwanuka, N., Lamunu, M., Namale, C., Tinka, L. K., Sanyu, A. N., Ggita, J. M., Turimumahoro, P., Babirye, D., et al. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-039895 · Cited by 17
Self-citationKatamba, A., Neuhauser, D. B., Smyth, K. A., Adatu, F., Katabira, E. T., & WHALEN, C. C. (2005) · PubMed · Cited by 15
Self-citationOpportunities to improve digital adherence technologies and TB care using human-centered design
Berger, C. A., Patel, D., Kityamuwesi, A., Ggita, J. M., Tinka, L. K., Turimumahoro, P., Neville, K., Chehab, L. Z., Chen, A., Gupta, N., et al. (2020) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.20.0184 · Cited by 14
Self-citationVariation in tuberculosis treatment outcomes and treatment supervision practices in Uganda
Berger, C. A., Kityamuwesi, A., Crowder, R. R., Lamunu, M., Tinka, L. K., Ggita, J. M., Sanyu, A. N., Namale, C., Oyuku, D., Chen, K. J., et al. (2020) · Journal of Clinical Tuberculosis and Other Mycobacterial Diseases · doi:10.1016/j.jctube.2020.100184 · Cited by 13
Self-citationBhandari, R. (2012) · Health Prospect · doi:10.3126/hprospect.v10i0.5651 · Cited by 5
Research works printed but not linked: 2
- Everwell Health Solutions. 99DOTS: low-cost monitoring and improving medication adherence. Bangalore: Everwell Health Solutions; 2021 [cited 2021 Apr 30]. Available from: https://www.99dots.org.
- StataCorp. Stata statistical software. Release 15. College Station (TX): StataCorp; 2017.
Cited by
Liu, X., Thompson, J., Dong, H., Sweeney, S., Li, X., Yuan, Y., Wang, X., He, W., Thomas, B., Xu, C., et al. (2023) · The Lancet Global Health · doi:10.1016/s2214-109x(23)00068-2 · Cited by 69
Manyazewal, T., Woldeamanuel, Y., Holland, D. P., Fekadu, A., & Marconi, V. C. (2022) · BMC Medicine · doi:10.1186/s12916-022-02521-y · Cited by 53
Wei, X., Hicks, J. P., Zhang, Z., Haldane, V. E., Pasang, P., Li, L., Yin, T., Zhang, B., Li, Y., Pan, Q., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(23)02270-5 · Cited by 53
Jerene, D., van Kalmthout, K., Levy, J., Alacapa, J., Deyanova, N., Dube, T., Mganga, A., Tasca, B. G., Bogdanov, A., Efo, E., et al. (2025) · The Lancet · doi:10.1016/s0140-6736(24)02847-2 · Cited by 42
Mohamed, M. S., Zary, M., Kafie, C., Chilala, C. I., Bahukudumbi, S., Foster, N., Gore, G. C., Fielding, K., Subbaraman, R., & Schwartzman, K. (2025) · BMC Infectious Diseases · doi:10.1186/s12879-025-11503-3 · Cited by 46
Metadata
- Authors
- Cattamanchi, A., Crowder, R., Kityamuwesi, A., Kiwanuka, N., Lamunu, M., Namale, C., Tinka, L. K., Nakate, A. S., Ggita, J., Turimumahoro, P., Babirye, D., Oyuku, D., Berger, C., Tucker, A., Patel, D., Sammann, A., Turyahabwe, S., Dowdy, D., & Katamba, A.
- Affiliations
- San Francisco General Hospital (US)
- Makerere University (UG)
- Johns Hopkins University (US)
- Ministry of Health (UG)
- Corresponding author
- Cattamanchi, Adithya
- ORCID
- Venue
- PLoS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2021-05-06
- Volume
- 18
- Issue
- 5
- Pages
- e1003628
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- PMC
- PMC8136841
- OpenAlex
- W3157487954
- Cited by
- 83
- References
- 21
- Citations by year
- 2026: 17 · 2025: 16 · 2024: 15 · 2023: 17 · 2022: 14 · 2021: 4
- FWCI
- 3.96
- Type
- journal article
- Language
- en
- Update notices
- new_version (2021-05-20)
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Funders
- The Stop TB Partnership (STBP/TBREACH/GSA/W6-37, (STBP/TBREACH/GSA/W6-37))
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Health Sciences › Health Professions › General Health Professions › Mobile Health and mHealth Applications
- Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
- Keywords
- tuberculosis, digital adherence technologies, treatment supervision, treatment completion, drug-susceptible pulmonary tuberculosis, HIV coinfection, sex differences, Uganda, mobile health
- MeSH terms
- Assessment of Medication Adherence, Adult, Antitubercular Agents, Female, Humans, Male, Middle Aged, Technology, Tuberculosis, Pulmonary, Uganda, Cluster Analysis, Drug Monitoring, Medication Adherence, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.